Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medgenics Inc (NASDAQ:MDGN)

5.35
Delayed Data
As of 4:00pm ET
 +0.09 / +1.71%
Today’s Change
3.09
Today|||52-Week Range
6.75
-11.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization145.0K177.0K225.0K240.0K
 
 
 
 
 
 
Operating ExpensesGross Income---177.0K-225.0K-240.0K
 
 
 
 
General Expenses14.2M17.5M18.7M28.2M
 
 
 
 
 
Research And Development7.2M7.3M8.3M15.4M
 
 
 
 
 
Total Operating Expenses14.4M17.6M18.9M28.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.4M-17.6M-18.9M-28.4M
 
 
 
 
 
Extraordinary Credit0.00720.0K585.0K0.00
 
 
 
Extraordinary Charge-2.3M-186.0K---9.5M
 
 
 
 
Interest Expense On Debt0.000.0020.0K20.0K
 
 
 
Other Expenses-93.0K-17.0K-48.0K-18.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.8M-17.1M-18.4M-38.0M
 
 
 
 
 
Income Taxes-1.7M-17.0K-12.0K-17.0K
 
 
 
 
 
Net Income-15.1M-17.1M-18.4M-38.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.0M17.6M19.2M26.8M
 
 
 
 
 
Shares To Calculate EPS Diluted11.0M17.7M19.3M26.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.37-$1.06-$1.00-$1.45
 
 
 
 
 
EPS Diluted-$1.37-$1.06-$1.00-$1.45